Adverum Biotechnologies Inc. buy Chardan Capital
Start price
19.07.24
/
50%
€1.38
Target price
19.07.25
€36.70
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 19.07.25. The prediction end date can be changed by Chardan_Capital at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Adverum Biotechnologies Inc. | - | - |
| iShares Core DAX® | 1.665% | 0.362% |
| iShares Nasdaq 100 | -0.475% | -3.195% |
| iShares Nikkei 225® | 2.620% | 1.174% |
| iShares S&P 500 | -0.091% | -1.597% |
Comments by Chardan_Capital for this prediction
In the thread Adverum Biotechnologies Inc. diskutieren
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target raised by analysts at Chardan Capital from $4.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ADVM provided by MarketBeat
Stopped prediction by Chardan_Capital for Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.51
19.03.24
19.03.24
€3.68
19.03.25
19.03.25
-8.61%
20.03.24
20.03.24
